NKT cells - New players in CAR cell immunotherapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NKT cells - New players in CAR cell immunotherapy?

Published:2018-10-09 Issue:6 Volume:101 Page:750-757
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Kriegsmann Katharina¹^ORCID,Kriegsmann Mark²,von Bergwelt-Baildon Michael³,Cremer Martin¹,Witzens-Harig Mathias¹

Affiliation:

1. Department of Hematology, Oncology and Rheumatology; University Hospital Heidelberg; Heidelberg Germany

2. Institute of Pathology; University Hospital Heidelberg; Heidelberg Germany

3. Department of Internal Medicine III; Ludwig Maximilian University; Munich Germany

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13170/fullpdf

Reference77 articles.

1. CAR T cell therapy: a game changer in cancer treatment;Almasbak;J Immunol Res,2016

2. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia;Porter;Sci Transl Med,2015

3. Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy;Bollino;Transl Res,2017

4. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells;Roark;J Immunol,1998

5. The burgeoning family of unconventional T cells;Godfrey;Nat Immunol,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Chimeric Antigen Receptor-engineered Invariant Natural Killer T Cells: Therapeutic Strategies for Cancer and the Tumor Microenvironment;Current Pharmaceutical Biotechnology;2024-11

2. A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects;Journal of Nanobiotechnology;2024-09-14

3. Study of LY9 as a potential biomarker for prognosis and prediction of immunotherapy efficacy in lung adenocarcinoma;PeerJ;2024-08-23

4. CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy;Clinical Reviews in Allergy & Immunology;2024-07-12

5. Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma;Cytotherapy;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3